Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Èíôîðìàöèÿ è êîììåð÷åñêàÿ ðåêëàìà > Ëåêàðñòâåííûå ïðåïàðàòû

Ëåêàðñòâåííûå ïðåïàðàòû Ðàçìåùåíèå ðåêëàìû ïëàòíîå. Ïèøèòå.

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 19.11.2016, 04:46
LingvaPsy LingvaPsy âíå ôîðóìà
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 10.08.2015
Ãîðîä: Óðàë
Ñîîáùåíèé: 1,060
Ñêàçàë(à) ñïàñèáî: 654
Ïîáëàãîäàðèëè 752 ðàç(à) çà 402 ñîîáùåíèé
LingvaPsy ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Àðáèäîë è ÂÎÇ

Äîáðûé äåíü, óâàæàåìûå ñïåöèàëèñòû. Íåäàâíî âñòðåòèëàñü ñëåäóþùàÿ èíôîðìàöèÿ: "Âñåìèðíîé îðãàíèçàöèåé çäðàâîîõðàíåíèÿ (ÂÎÇ) áûëî ïðèíÿòî ðåøåíèå î âêëþ÷åíèè ïðåïàðàòà «Àðáèäîë» (óìèôåíîâèð) â ãðóïïó ïðåïàðàòîâ ñ ïðÿìûì ïðîòèâîâèðóñíûì äåéñòâèåì ìåæäóíàðîäíîãî êëàññèôèêàòîðà ëåêàðñòâåííûõ ñðåäñòâ – Àíàòîìî-òåðàïåâòè÷åñêî-õèìè÷åñêîé êëàññèôèêàöèè (ÀÒÕ). Òàêèì îáðàçîì, â Ðîññèè òåïåðü åñòü ñâîé îðèãèíàëüíûé ïðîòèâîâèðóñíûé ïðåïàðàò äëÿ ëå÷åíèÿ ãðèïïà è ÎÐÂÈ, äåéñòâèå êîòîðîãî ïðèçíàíî ÂÎÇ."
Ïî ðàíåå ïðî÷èòàííûì ìàòåðèàëàì ÐÌÑ ó ìåíÿ ñëîæèëîñü ìíåíèå, ÷òî Àðáèäîë - ïðåïàðàò ñ íåäîêàçàííîé ýôôåêòèâíîñòüþ èç êàòåãîðèè "ôóôëîìèöèíîâ". Òàê êàê æå âñå-òàêè íà ñàìîì äåëå? È ÷òî îçíà÷àåò âêëþ÷åíèå ïðåïàðàòà â ýòîò êëàññèôèêàòîð?
Äîáàâëþ, ÷òîáû íå âîçíèêàëî ñîìíåíèé: ÿ íèêàêèì îáðàçîì íå îòíîøóñü ê ëèöàì, ïðîèçâîäÿùèì, ðåêëàìèðóþùèì Àðáèäîë èëè çàèíòåðåñîâàííûì â åãî ðàñïðîñòðàíåíèè. Ññûëêà íà óêàçàííóþ èíôîðìàöèþ áûëà ïðåäîñòàâëåíà ìíå ïðè îáñóæäåíèè "÷åì ëå÷èòü ÎÐÂÈ" íà ìàìñêîì ôîðóìå (è âîò äåâóøêà, åå ïðåäîñòàâèâøàÿ, êàê ðàç âûçûâàåò ñîìíåíèÿ â ñâîåé íåçàèíòåðåñîâàííîñòè). Õî÷åòñÿ ðàçîáðàòüñÿ äëÿ ñåáÿ è äî äðóãèõ äîíåñòè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 19.11.2016, 09:00
dobrada dobrada âíå ôîðóìà ÂÐÀ×
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 10.06.2009
Ãîðîä: Àðõèïî-Îñèïîâêà, Êðàñíîäàðñêèé êðàé
Ñîîáùåíèé: 11,148
Ñêàçàë(à) ñïàñèáî: 4
Ïîáëàãîäàðèëè 5,403 ðàç(à) çà 5,285 ñîîáùåíèé
dobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådobrada ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ññûëêó ïðåäîñòàâüòå
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 19.11.2016, 09:12
LingvaPsy LingvaPsy âíå ôîðóìà
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 10.08.2015
Ãîðîä: Óðàë
Ñîîáùåíèé: 1,060
Ñêàçàë(à) ñïàñèáî: 654
Ïîáëàãîäàðèëè 752 ðàç(à) çà 402 ñîîáùåíèé
LingvaPsy ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Íå çíàþ, íàñêîëüêî çàñëóæèâàåò äîâåðèÿ äàííîå èçäàíèå. Íàçâàíèå íå âïå÷àòëèëî.

Íó è, ñ Âàøåãî ïîçâîëåíèÿ, âîò åùå èç òîé æå ñåðèè, íî ïðî Îöèëëîêîêöèíóì [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Âèæó "ïðàâèëüíûå ñëîâà": äâîéíîå ñëåïîå ïëàöåáî-êîíòðîëèðóåìîå, Êîêðåéí, Ïàáìåä, ìåòààíàëèç, íî îñòàåòñÿ îùóùåíèå íàäóâàòåëüñòâà. Ñ îöèëëîêîêöèíóìîì, êàê ÿ ïîíÿëà, ñóùåñòâóåò ëèøü ïîâîä äëÿ äàëüíåéøåãî èññëåäîâàíèÿ (÷òî âîîáùå óäèâèòåëüíî äëÿ ãîìåîïàòèè). È ïîêà íå ñàì ìåòààíàëèç âûïîëíåí, à ëèøü îïèñàíû ïðåäïîñûëêè ê íåìó, âåðíî? À ñ Àðáèäîëîì?
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 19.11.2016, 09:25
BBC BBC âíå ôîðóìà
ìîäåðàòîð ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 31,518
Ïîáëàãîäàðèëè 4,832 ðàç(à) çà 3,086 ñîîáùåíèé
BBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âåðîÿòíî ðå÷ü èäåò îá ýòîé ïóáëèêàöèè.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Äà, òàêè umifenovir â íåé åñòü, íî ÷èòàåì âíèìàòåëüíî
Öèòàòà:
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution EB15.R7); 1969, 173, 10 (Resolution EB43.R9); Resolution EB115.R4 (EB115/2005/REC/1)], the following names are selected as Recommended International Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine or pharmacy.
__________________
Ñ óâàæåíèåì,
Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 19.11.2016, 09:49
BBC BBC âíå ôîðóìà
ìîäåðàòîð ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 31,518
Ïîáëàãîäàðèëè 4,832 ðàç(à) çà 3,086 ñîîáùåíèé
BBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
 îòíîøåíèè îöèëëîêîêöèíóìà ïðèìåíåí òîò æå ïðèåì - ññûëêà íà àâòîðèòåòíûé èñòî÷íèê, ãäå äåéñòâèòåëüíî âèäíî íàçâàíèå óïîìÿíóòîãî ñíàäîáüÿ.
Ðàñ÷åò íà òî, ÷òî 99% èç ïåðåøåäøèõ ïî ññûëêå ÷èòàòü òåêñò íå áóäåò, à èç òåõ êòî áóäåò, áîëüøàÿ ÷àñòü íå äî÷èòàåò äî âûâîäîâ
Ñìîòðèì
Öèòàòà:
Key results
The findings from the two prevention trials did not show that Oscillococcinum ® can prevent the onset of flu. Although the results from the four other clinical trials suggested that Oscillococcinum ® relieved flu symptoms at 48 hours, this might be due to bias in the trial methods.
Ïðåäïîëàãàòü ìîæíî âñå, ÷òî óãîäíî
Öèòàòà:
The overall standard of research reporting was poor...
therefore judged the evidence overall as low quality,
preventing clear conclusions from being made about Oscillococcinum ® in the prevention or treatment of flu and flu-like illness.

There is insufficient good evidence to enable robust conclusions to be made about
Ôðàçû î "íåîáõîäèìîñòè äàëüíåéøèõ èññëåäîâàíèé" â äàííîì êîíòåêñòå íà ðóññêèé ïîíÿòíûé ïåðåâîäÿòñÿ êàê "èññëåäîâàëè, îòâåòà íå ïîëó÷èëè - ãîâîðèòü íå î ÷åì. Õîòèòå çíàòü èñòèíó - íó... åñëè íå ëåíü èññëåäóéòå äàëüøå"
__________________
Ñ óâàæåíèåì,
Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 19.11.2016, 10:20
LingvaPsy LingvaPsy âíå ôîðóìà
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 10.08.2015
Ãîðîä: Óðàë
Ñîîáùåíèé: 1,060
Ñêàçàë(à) ñïàñèáî: 654
Ïîáëàãîäàðèëè 752 ðàç(à) çà 402 ñîîáùåíèé
LingvaPsy ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Ñïàñèáî, âñå ÿñíî. Óäðó÷àåò íåêîìïåòåíòíîñòü (èëè ñîçíàòåëüíîå î÷êîâòèðàòåëüñòâî) èçäàíèé ïðè ïóáëèêàöèÿõ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 01.12.2016, 23:36
Àâàòàð äëÿ Korzun
Korzun Korzun âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 15.03.2005
Ãîðîä: Ãåðìàíèÿ
Ñîîáùåíèé: 24,426
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 10,435 ðàç(à) çà 9,605 ñîîáùåíèé
Korzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKorzun ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îöèëëîêîêöèíóì - ýòî íå ëåêàðñòâî, à ãîìåîïàòèÿ. Ò.å. ïîëíàÿ ñîáà÷üÿ ÷óøü!
FDA (ÑØÀ) íåäàâíî îáÿçàëî ïðîèçâîäèòåëåé ãîìåîïàòèè ïèñàòü íà ñâîèõ êîðîáî÷êàõ ÷òî-òî ïîäîáíîå: "íå ÿâëÿåòñÿ âîîáùå ëåêàðñòâîì, íå èìååò íàó÷íûõ äîêàçàòåëüñòâ ýôôåêòèâíîñòè".
Ãîìåîïàòèÿ - ýòî ñâîåãî ðîäà ðåëèãèÿ, êîòîðàÿ ÷ðåçâû÷àéíî äàëåêà îò ñîâðåìåííîé ìåäèöèíû.
__________________
Àëåêñàíäð Èâàíîâè÷
ñ ïîæåëàíèÿìè êðåïêîãî çäîðîâüÿ
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 03:09.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.